PPARA and ovarian cancer: Additionally in endometrial cancer [180], breast cancer [181], glioblastoma [182], colon cancer [68,183], ovarian cancer [56], medulloblastoma [57], neuroblastoma [59], pancreatic cancer [184], and NSCLC [185], the activation of PPARα induced apoptosis.